IDÀúÀå 
ùȭ¸éÀ¸·Î
°øÁö»çÇ×
°Ô½ÃÆÇ
ÄûÁîÄûÁî
ÁÖÀÓ±³¼ö Àλ縻
µ¿¹®È¸Àå Àλ縻
±³½Ç¿ª»ç
¿ª´ë ÁÖÀÓ±³¼ö
¿ª´ë µ¿¹®È¸Àå
±³½Ç¿ø ¼Ò°³
Àü°øÀÇ ¼Ò°³
ÀÚÁÖ ¿¬¶ôÇսôÙ
°ø½ÄÇà»ç
¿ì¸®´Â Çϳª
Ãß¾ïÀÇ ¾Ù¹ü
News Letter
¿¬º¸
¼ö¿ä Conference
¿©Àǵµ¼º¸ð
°­³²¼º¸ð
ÀÇÁ¤ºÎ¼º¸ð
¼ººó¼¾Æ®
¼º¸ðÀÚ¾Ö
¼º°¡
¼º¹Ù¿À·Î
´ëÀü¼º¸ð
°¡Å縯½ÉÆ÷Áö¿ò
µ¿¹®Çмú´ëȸ
º¸¹°Ã¢°í
µðīŬ·´
Á¤º¸¼öÁ¤
ÀÔÅð¿ø¼ö¼ú °ü¸®

 
ÀÛ¼ºÀÚ ºñ´¢±â°úÇб³½Ç µî·ÏÀÏ 2010-09-13 11:50:13
Á¶È¸ 609 ´Ù¿î 0
Á¦¸ñ   9¿ù15ÀÏ ¼ö¿äÃʵ¶È¸ °øÁö
÷ºÎÆÄÀÏ    
³»¿ë
ÁÖÁ¦ : Treatment of localized prostate cancer with high risk

ÁÂÀå : °íÁؼº ±³¼ö

¹ßÇ¥ÀÚ :
R3 ¼ÕÁØÈ£
1. Can J Urol. 2008 Dec;15(6):4375-80.
High risk prostate cancer: evolving definition and approach to management.
2. J Urol. 2007 Aug;178(2):493-9; discussion 499. Epub 2007 Jun 11.
Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.

R2 ¾È¼±±¹
3. J Urol. 2007 Mar;177(3):911-5.
Long-term survival in men with high grade prostate cancer: a comparison between conservative treatment, radiation therapy and radical prostatectomy--a propensity scoring approach.
4. Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):327-33. Epub 2008 Aug 15.
Final report of multicenter Canadian Phase III randomized trial of 3 versus 8 months of neoadjuvant androgen deprivation therapy before conventional-dose radiotherapy for clinically localized prostate cancer.

ÀϽà : 2010³â 9¿ù 15ÀÏ (¼ö) ¿ÀÈÄ 6½Ã 00ºÐ
Àå¼Ò : º»°ü ÁöÇÏ1Ãþ 2ȸÀǽÇ

ÀÌÀü±Û   ¼­¿ï¼º¸ðº´¿ø-ºÏ°æ´ëÇÐ ºñ´¢±â°ú ½ÉÆ÷Áö¾ö
ÀÌÈÄ±Û   (ºÎ°í) Á¤À±¼® µ¿¹® ¸ðÄ£»ó

 
¸®Çôޱâ